Life Sciences Tools & Services · NYSE

IQVIqvia Holdings Inc.

Last close
$265.12 -2.2%
52-week range
$154.50 to $284.50
Market cap
$43.7B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$16.3B
+6% vs FY24
Net income
$1.36B
-1% vs FY24
Free cash flow
$2.05B
-3% vs FY24
Net cash
-$13.6B
Cash $2.14B, debt $15.7B

Stock price

+238% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
32.2x
16.6x257x
38th percentile, below its median of 36.0x
Price / sales
2.5x
1.7x4.0x
45th percentile, below its median of 2.6x
EV / EBITDA
16.7x
12.3x26.3x
28th percentile, below its median of 18.2x
Price / free cash flow
21.0x
13.6x45.6x
25th percentile, below its median of 25.0x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
32.2x
Earnings yield
3.1%
Price / sales
2.5x
Price / book
6.6x
Price / operating cash flow
16.0x
EV / EBITDA
16.7x
EV / sales
3.3x
Free cash flow yield
4.8%

Profitability

Gross margin
33.1%
Operating margin
12.8%
Net margin
8.1%
Return on equity
20.9%
Return on capital
8.2%

Growth per year

Revenue, 3 years
+4.2%
Revenue, 5 years
+7.5%
Revenue, 9 years
+10.2%
EPS, 3 years
+11.1%

Balance sheet

Cash and investments
$2.42B
Total debt
$16.1B
Net cash
-$13.6B
Debt / equity
2.41x
Current ratio
0.83x

Shares and dividend

Shares outstanding
165M
Share count, 5 years
-11.0%
Beta, 1 year
0.68
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $4.43B
RevenueNet income
Gross profitLatest quarter $1.50B
EBITDALatest quarter $893M
Margins34 / 13 / 8%
GrossOperatingNet
Earnings per shareLatest quarter $2.10
Cash flowLatest quarter $825M
OperatingCapexFree
Cash vs debtLatest quarter $2.42B
Cash and investmentsTotal debt
P/E historyNow 32.2x
P/E, median 36.0x dashed
P/S historyNow 2.5x
P/S, median 2.6x dashed

Where the revenue comes from

Technology and Analytics Solutions went from 40% to 41% of revenue in 3 years

Share of revenue by business segment, fiscal 2022 to 2025, as reported in the 10-K.

Research and Development SolutionsTechnology and Analytics SolutionsContract Sales and Medical Solutions
FY22
55%40%
$14.4B
FY23
56%39%
$15.0B
FY24
55%40%
$15.4B
FY25
55%41%
$16.3B
Fiscal 2025 by business segment
Business segmentRevenueSharevs FY24
Research and Development Solutions$8.90B54.5%+4%
Technology and Analytics Solutions$6.63B40.6%+8%
Contract Sales and Medical Solutions$788M4.8%+10%

Life Sciences Tools & Services peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
TMO Thermo Fisher Scientific Inc. $259B +8% 17.9%36.9x5.5x 88th percentile
A Agilent Technologies, Inc. $49.0B +9% 22.2%34.2x6.7x 64th percentile
WAT Waters Corp $45.2B +81% 4.7%198x8.1x 90th percentile
IQV Iqvia Holdings Inc. $43.7B +9% 12.8%32.2x2.5x 38th percentile
MTD Mettler Toledo International Inc/ $34.6B +7% n/a37.7x8.2x 58th percentile
ILMN Illumina, Inc. $31.3B +6% 21.1%35.6x6.9x 25th percentile

The company

Sector
Health Care
Industry
Life Sciences Tools & Services
Founded
2016
Headquarters
Durham, NC
Fiscal year ends
December
Website
iqvia.com

What it does

IQVIA Holdings, Inc. is an American health information technology and clinical research company headquartered in Durham, North Carolina. The company provides clinical research services, healthcare analytics, technology solutions, and commercial outsourcing services to pharmaceutical, biotechnology, medical device, and healthcare organizations worldwide.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about IQV.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 787 active funds. Crowd level: quiet.

Open the Smart money tab